Bucak Abdulkadir, Ulu Sahin, Oruc Serdar, Yucedag Fatih, Tekin Mustafa Said, Karakaya Fatıma, Aycicek Abdullah
Department of Otolaryngology, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey.
Laryngoscope. 2014 Jul;124(7):1678-81. doi: 10.1002/lary.24551. Epub 2013 Dec 31.
OBJECTIVES/HYPOTHESIS: Bell palsy can be defined as an idiopathic, acute, facial nerve palsy. Although the pathogenesis of Bell palsy is not fully understood, inflammation seems to play important role. Neutrophil-to-lymphocyte (NLR) ratio was defined as a novel potential marker to determine inflammation and it is routinely measured in peripheral blood. Our goal was to investigate the relationship between Bell palsy and inflammation by using NLR.
Retrospective study.
The 54 patients who were followed up for Bell palsy for a period of 1 to 3 years, along with 45 age- and sex-matched controls, were included in the study. An automated blood cell counter was used for NLR measurements. All patients were treated with prednisone, 1 mg/kg per day with a progressive dose reduction. Patients were classified according to the House-Brackmann grading system at posttreatment period. Those with House-Brackmann grade I and grade II were regarded as satisfactory recovery; and those with House-Brackmann grade III to grade VI were regarded as nonsatisfactory recovery.
The mean NLR and neutrophil values in patients with Bell palsy were significantly higher than in the control group (P=0.001 and P<0.001, respectively). In addition, NLR levels were higher in nonsatisfactory recovered patients compared with satisfactory recovered ones (P<0.001).
This is the first study investigating the relationship between NLR levels and Bell palsy and its prognosis. Our result suggest that while evaluating Bell palsy patients, NLR might be taken into account as a novel potential marker to predict the patients' prognosis.
3b.
目的/假设:贝尔面瘫可定义为一种特发性急性面神经麻痹。尽管贝尔面瘫的发病机制尚未完全明确,但炎症似乎起着重要作用。中性粒细胞与淋巴细胞(NLR)比值被定义为一种新型的潜在炎症标志物,通常在外周血中进行检测。我们的目标是通过使用NLR来研究贝尔面瘫与炎症之间的关系。
回顾性研究。
本研究纳入了54例随访1至3年的贝尔面瘫患者以及45例年龄和性别匹配的对照者。使用自动血细胞计数器测量NLR。所有患者均接受泼尼松治疗,剂量为每日1mg/kg,并逐渐减量。在治疗后根据House-Brackmann分级系统对患者进行分类。House-Brackmann I级和II级的患者被视为恢复良好;House-Brackmann III级至VI级的患者被视为恢复不佳。
贝尔面瘫患者的平均NLR和中性粒细胞值显著高于对照组(分别为P=0.001和P<0.001)。此外,恢复不佳的患者NLR水平高于恢复良好的患者(P<0.001)。
这是第一项研究NLR水平与贝尔面瘫及其预后关系的研究。我们的结果表明,在评估贝尔面瘫患者时,NLR可作为一种新型的潜在标志物来预测患者的预后。
3b。